[SCHEDULE 13G/A] Autonomix Medical, Inc. SEC Filing

Rhea-AI Filing Summary

Amendment to Schedule 13G for Autonomix Medical, Inc. (AMIX) filed by a group of investment entities and individuals discloses that the listed Reporting Persons—Cavalry Fund I LP; C/M Capital Master Fund, LP; C/M Capital Partners, LP; Mercer Street Global Opportunity Fund, LLC; Mercer Street Capital Partners, LLC; Thomas Walsh; and Jonathan Juchno—report zero shares beneficially owned of Autonomix common stock (CUSIP 05330T205), representing 0% of the class. The filing identifies relationships among the entities: C/M Capital Partners is manager to the Cavalry and C/M Master funds, Mercer Capital Partners manages the Mercer fund, and Messrs. Walsh and Juchno are managing members or control persons for the relevant managers. The business address for the Reporting Persons is 61 82 E. Allendale Rd. Ste 5B, Saddle River, NJ 07458. The signatories certify the securities were not acquired to influence control of the issuer.

Positive

• None.

Negative

• Reporting Persons disclose 0 shares and 0% ownership of Autonomix common stock, indicating no current beneficial stake by the listed funds or individuals
• No group ownership or >5% holdings reported, so the filing provides no evidence of coordinated influence or acquisition activity

Insights

Securities Analyst

TL;DR Reporting persons disclose no beneficial ownership of AMIX shares, indicating no current stake or control influence.

The Schedule 13G/A lists multiple funds and associated managers and shows 0 shares and 0% ownership for each Reporting Person. That outcome is a clear, objective disclosure: the Funds and named individuals do not currently hold beneficial ownership in Autonomix common stock under the metrics reported. From a market-impact perspective this filing is neutral to slightly negative for takeover- or activist-related speculation because it removes these entities as current holders or potential coordinating holders. The certification language also affirms the absence of intent to influence control.

Corporate Governance Expert

TL;DR Governance implications are minimal: the filing documents relationships but reports no holdings or group activity.

The document maps the governance and management ties among investment entities and two individuals, which is useful for transparency, yet each Reporting Person discloses 0.00 shared or sole voting and dispositive power and 0% ownership. There are no group formations, no >5% ownership, and no indications of contested control. Signatures from the managers and individuals are provided, completing disclosure requirements. Overall, this is a compliance filing without material governance impact.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Autonomix Medical, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

05330T205

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 05330T205

1

Names of Reporting Persons

Cavalry Fund I LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 05330T205

1

Names of Reporting Persons

C/M Capital Master Fund, LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 05330T205

1

Names of Reporting Persons

C/M Capital Partners, LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 05330T205

1

Names of Reporting Persons

Mercer Street Global Opportunity Fund, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 05330T205

1

Names of Reporting Persons

Mercer Street Capital Partners, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 05330T205

1

Names of Reporting Persons

Thomas Walsh

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP No. 05330T205

1

Names of Reporting Persons

Jonathan Juchno

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Autonomix Medical, Inc.
(b)	Address of issuer's principal executive offices: 21 Waterway Avenue, Suite 300, The Woodlands, TX 77380.
Item 2.
(a)	Name of person filing: (i) Cavalry Fund I LP, a Delaware limited partnership ("Cavalry Fund I"); (ii) C/M Capital Master Fund, LP, a Delaware limited partnership ("C/M Master Fund"); (iii) C/M Capital Partners, LP, a Delaware limited partnership ("C/M Capital Partners"); (iv) Mercer Street Global Opportunity Fund, LLC, a Delaware limited liability company ("Mercer Fund," together with Cavalry Fund I and C/M Master Fund, the "Funds"); (v) Mercer Street Capital Partners, LLC, a Delaware limited liability company ("Mercer Capital Partners"); (vi) Thomas Walsh ("Mr. Walsh"); and (vii) Jonathan Juchno ("Mr. Juchno"). The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." This filing is filed by the Reporting Persons with respect to the common stock, par value $0.001 per share, of Autonomix Medical, Inc., a Delaware corporation, that were held by the Funds. C/M Capital Partners is the investment manager to Cavalry Fund I and C/M Master Fund. Messrs. Walsh and Juchno are the managing members of the general partner of C/M Capital Partners. Mercer Capital Partners is the investment manager to Mercer Fund. Mr. Juchno controls Mercer Capital Partners. Mr. Walsh may have been deemed to beneficially own the securities that were held by Cavalry Fund I and C/M Master Fund. Mr. Juchno may have been deemed to beneficially own the securities that were held by the Funds.
(b)	Address or principal business office or, if none, residence: The address of the business office of each of the Reporting Persons is 61 82 E. Allendale Rd. Ste 5B, Saddle River, New Jersey 07458.
(c)	Citizenship: Cavalry Fund I is a limited partnership organized under the laws of the State of Delaware. C/M Master Fund is a limited partnership organized under the laws of the State of Delaware. C/M Capital Partners is a limited partnership organized under the laws of the State of Delaware. Mercer Fund is a limited liability company organized under the laws of the State of Delaware. Mercer Capital Partners is a limited liability company organized under the laws of the State of Delaware. Mr. Walsh is a citizen of the United States. Mr. Juchno is a citizen of the United States.
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 05330T205
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(b)	Percent of class: 0%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
	(ii) Shared power to vote or to direct the vote: The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
	(iii) Sole power to dispose or to direct the disposition of: The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
	(iv) Shared power to dispose or to direct the disposition of: The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Cavalry Fund I LP

Signature:	/s/ Thomas Walsh
Name/Title:	By: Cavalry Fund I GP LLC, General Partner, By: Thomas Walsh, Manager
Date:	08/14/2025

C/M Capital Master Fund, LP

Signature:	/s/ Thomas Walsh
Name/Title:	By: C/M Global GP, LLC, its General Partner, By: Thomas Walsh, Manager
Date:	08/14/2025

C/M Capital Partners, LP

Signature:	/s/ Thomas Walsh
Name/Title:	By: Thomas Walsh, Partner
Date:	08/14/2025

Mercer Street Global Opportunity Fund, LLC

Signature:	/s/ Jonathan Juchno
Name/Title:	NFSO, LLC, its General Partner, By: Jonathan Juchno, Authorized Representative
Date:	08/14/2025

Mercer Street Capital Partners, LLC

Signature:	/s/ Jonathan Juchno
Name/Title:	Jonathan Juchno, Authorized Representative
Date:	08/14/2025

Thomas Walsh

Signature:	/s/ Thomas Walsh
Name/Title:	Thomas Walsh, individually
Date:	08/14/2025

Jonathan Juchno

Signature:	/s/ Jonathan Juchno
Name/Title:	Jonathan Juchno, individually
Date:	08/14/2025

FAQ

Who filed the Schedule 13G/A for Autonomix Medical, Inc. (AMIX)?

The filing was made by Cavalry Fund I LP, C/M Capital Master Fund, LP, C/M Capital Partners, LP, Mercer Street Global Opportunity Fund, LLC, Mercer Street Capital Partners, LLC, Thomas Walsh, and Jonathan Juchno.

How many Autonomix (AMIX) shares do the reporting persons beneficially own?

Each Reporting Person reports 0 shares beneficially owned, representing 0% of the class.

Does the filing indicate any intent to influence control of Autonomix?

No. The certification states the securities were not acquired and are not held for the purpose of changing or influencing the issuer's control.

Where is the principal business address for the Reporting Persons?

The business office address listed is 61 82 E. Allendale Rd. Ste 5B, Saddle River, New Jersey 07458.

Are there any >5% ownership holders disclosed in this filing?

No. Item 5 confirms ownership of 5 percent or less of the class.